Combating Winter Respiratory Virus Transmission Through Prevention and Vaccination

Respiratory virus transmission intensifies during winter months due to colder temperatures forcing people indoors, leading to increased close contact and reduced ventilation. This environment facilitates the easy spread of respiratory droplets expelled through talking, coughing, or sneezing, especially at distances under one meter. Prevention measures are emphasized annually, with vaccination, particularly against influenza for high-risk groups, being a highly effective strategy. During epidemiological weeks 24 and 25, viral circulation peaked at 54% positivity, primarily driven by influenza A, influenza B, and rhinovirus. Influenza is distinct from a common cold, presenting with severe symptoms like high fever, muscle aches, headaches, and significant general malaise, along with a higher risk of complications such as bacterial superinfections. While the exact epidemiology varies yearly, influenza outbreaks typically last six to eight weeks and can see resurgences in spring, underscoring the ongoing benefit of vaccination. The significant reduction in hospitalizations for infants due to RSV has improved healthcare capacity, ensuring better availability of beds for other conditions. Public health policies like vaccination and the use of Nirsevimab are expected to maintain support from both the public and authorities, offering a means to mitigate the impact of winter respiratory illnesses.